Alpha Tau Medical Ltd., (DRTS): Price and Financial Metrics Recent IPO
GET POWR RATINGS... FREE!
DRTS Stock Price Chart Interactive Chart >
DRTS Price/Volume Stats
| Current price | $9.30 | 52-week high | $20.65 |
| Prev. close | $11.60 | 52-week low | $4.68 |
| Day low | $9.20 | Volume | 105,598 |
| Day high | $11.85 | Avg. volume | 467,392 |
| 50-day MA | $8.51 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 618.72M |
Alpha Tau Medical Ltd., (DRTS) Company Bio
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
DRTS Price Returns
| 1-mo | N/A |
| 3-mo | -21.19% |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...